Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Viola Fühner

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2018
Epitope Mapping via Phage Display from Single-Gene LibrariesViola Fühner, Philip Alexander Heine, Kilian Johannes Carl Zilkens, et al.
Biotechnology and Bioengineering|June 11, 2015
Expression of the human cytomegalovirus pentamer complex for vaccine use in a CHO systemIrmgard Hofmann, Yingxia Wen, Claudio Ciferri, et al.
Bioorganic & Medicinal Chemistry Letters|October 23, 2020
Generation of recombinant antibodies against human tissue kallikrein 7 to treat skin diseasesAna Flávia S Laureano, Marcelo B Zani, Aquiles M Sant'Ana, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 7, 2023
Mapping Epitopes by Phage DisplayStephan Steinke, Kristian Daniel Ralph Roth, Ruben Englick, et al.
Frontiers in Cellular and Infection Microbiology|July 26, 2021
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and TherapyKristian Daniel Ralph Roth, Esther Veronika Wenzel, Maximilian Ruschig, et al.
Nature Communications|March 12, 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interfaceFederico Bertoglio, Doris Meier, Nora Langreder, et al.
Cell Reports|July 17, 2021
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutationsFederico Bertoglio, Viola Fühner, Maximilian Ruschig, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Methods in Molecular Biology (Clifton, N.J.)|December 13, 2018
Epitope Mapping via Phage Display from Single-Gene LibrariesViola Fühner, Philip Alexander Heine, Kilian Johannes Carl Zilkens, et al.
Biotechnology and Bioengineering|June 11, 2015
Expression of the human cytomegalovirus pentamer complex for vaccine use in a CHO systemIrmgard Hofmann, Yingxia Wen, Claudio Ciferri, et al.
Bioorganic & Medicinal Chemistry Letters|October 23, 2020
Generation of recombinant antibodies against human tissue kallikrein 7 to treat skin diseasesAna Flávia S Laureano, Marcelo B Zani, Aquiles M Sant'Ana, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 7, 2023
Mapping Epitopes by Phage DisplayStephan Steinke, Kristian Daniel Ralph Roth, Ruben Englick, et al.
Frontiers in Cellular and Infection Microbiology|July 26, 2021
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and TherapyKristian Daniel Ralph Roth, Esther Veronika Wenzel, Maximilian Ruschig, et al.
Nature Communications|March 12, 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interfaceFederico Bertoglio, Doris Meier, Nora Langreder, et al.
Cell Reports|July 17, 2021
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutationsFederico Bertoglio, Viola Fühner, Maximilian Ruschig, et al.
Pageof 2